Clinical Trial

Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine

Study acronym: AITX
Recruiting
View on ClinicalTrials.gov →
Summary
The AITX study is an international, multicenter survey exploring how kidney transplant recipients perceive artificial intelligence (AI) in medicine and, specifically, a system that predicts graft loss risk. Through an open-ended online questionnaire distributed across transplant centers and patient associations in France and the United States, the study captures patients' expectations, concerns, and the perceived impact of AI-driven prediction on their daily lives. Responses are analyzed using large language models (LLMs) with systematic human verification. The study aims to ensure that the deployment of AI in transplantation is ethical, transparent, and patient-centered.
Trial Details
NCT Number NCT07600541
Lead Sponsor Paris Translational Research Center for Organ Transplantation
Conditions Kidney Transplant
Enrollment 1,000 participants
Start Date 2026-04-15
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-20